Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$33.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 11 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 30 most recent Form 4 transactions.
| Aug 10 | BLSM | BlossomHill Therapeutics,… | PBUY | 312,500 | $16.00 | $5M | +9.5% | Open the original filing on SEC.gov |
| Aug 10 | BLSM | BlossomHill Therapeutics,… | CCONV | 1.7M | — | — | +106.3% | Open the original filing on SEC.gov |
| Aug 10 | BLSM | BlossomHill Therapeutics,… | CCONV | 1.6M | — | — | — | Open the original filing on SEC.gov |
| Aug 6 | BLSM | BlossomHill Therapeutics,… | AGRANT◆ | 23,904 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | BBOT | BridgeBio Oncology… | JOTHER | 130,865 | — | — | +2.2% | Open the original filing on SEC.gov |
| Jul 1 | BBOT | BridgeBio Oncology… | JOTHER | 1.7M | — | — | +51.6% | Open the original filing on SEC.gov |
| Jul 1 | BBOT | BridgeBio Oncology… | JOTHER | 2.7M | — | — | +123.1% | Open the original filing on SEC.gov |
| Jul 1 | BBOT | BridgeBio Oncology… | JOTHER | 4.5M | — | — | -100.0% | Open the original filing on SEC.gov |
| Jun 16 | BBOT | BridgeBio Oncology… | AGRANT◆ | 31,675 | — | — | — | Open the original filing on SEC.gov |
| Jan 26 | HLXC | Helix Acquisition Corp.… | PBUY↺ | 800,000 | $10.00 | $8M | — | Open the original filing on SEC.gov |
| Jan 26 | HLXC | Helix Acquisition Corp.… | AGRANT↺ | 497,500 | $10.00 | $5M | — | Open the original filing on SEC.gov |
| Jan 22 | HLXC | Helix Acquisition Corp.… | JOTHER◆↺ | 718,750 | — | — | — | Open the original filing on SEC.gov |
| Sep 30, 2025 | MLTX | MoonLake Immunotherapeutic… | SSELL | 5,827 | $6.96 | $40.6K | -0.3% | Open the original filing on SEC.gov |
| Sep 29, 2025 | MLTX | MoonLake Immunotherapeutic… | SSELL | 2.8M | $6.61 | $18.5M | -58.3% | Open the original filing on SEC.gov |
| Sep 29, 2025 | MLTX | MoonLake Immunotherapeutic… | SSELL | 3.4M | $7.58 | $25.7M | -41.4% | Open the original filing on SEC.gov |
| Sep 29, 2025 | MLTX | MoonLake Immunotherapeutic… | SSELL | 232,460 | $8.40 | $2M | -2.8% | Open the original filing on SEC.gov |
| Sep 29, 2025 | MLTX | MoonLake Immunotherapeutic… | SSELL | 70,748 | $9.38 | $663.6K | -0.8% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | MEXER◆ | 4.2M | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | DTOISS◆ | 307,874 | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 284,571 | — | — | +5.0% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 1.8M | — | — | +114.3% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 1.9M | — | — | — | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 5.6M | $10.72 | $60M | +8,072% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 639,110 | $10.72 | $6.8M | +70.7% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | AGRANT | 760,496 | $10.72 | $8.2M | +53.3% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | DTOISS | 152,940 | — | — | -3.3% | Open the original filing on SEC.gov |
| Aug 11, 2025 | BBOT | BridgeBio Oncology… | MEXER | 4.2M | — | — | +819.7% | Open the original filing on SEC.gov |
| Jun 11, 2025 | BMEA | Biomea Fusion, Inc. | AGRANT◆ | 91,970 | — | — | — | Open the original filing on SEC.gov |